Additional analyses of publicly available cell line mRNA data in CCLE (Figure 2C) and of a subset of BC samples analyzed for EHD2 expression (Figure 2A), further reinforce the conclusion that high cytoplasmic EHD2 expression is a feature of BC with basal-like/triple-negative features. This evidence concerns the gene EHD2 and breast cancer.